Indian drug companies are poised to transform diabetes treatment in India as they prepare to launch cost-effective generic versions of Empagliflozin, a key diabetes drug, after the patent expiration. This move is expected to reduce expenses and enhance accessibility for over 10 crore diabetic patients in the country. Mankind Pharma and other pharmaceutical companies will introduce the medication at a much lower price compared to the original, which will not only ease financial burdens but also improve heart and kidney health in diabetic individuals. This development marks a significant milestone in the healthcare sector, offering hope to millions grappling with diabetes in India.<\/p>\n","protected":false},"excerpt":{"rendered":"
Indian drug companies are poised to transform diabetes treatment in India as they prepare to launch cost-effective generic versions of Empagliflozin, a key diabetes drug, after the patent expiration. This move is expected to reduce expenses and enhance accessibility for over 10 crore diabetic patients in the country. Mankind Pharma and other pharmaceutical companies will […]<\/p>\n","protected":false},"author":0,"featured_media":73343,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[25],"tags":[],"aioseo_notices":[],"featured_image_urls":{"full":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3.jpg",1253,836,false],"thumbnail":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3-150x150.jpg",150,150,true],"medium":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3-300x200.jpg",300,200,true],"medium_large":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3-768x512.jpg",640,427,true],"large":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3-1024x683.jpg",640,427,true],"1536x1536":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3.jpg",1253,836,false],"2048x2048":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-118827364imgsize-23160-3.jpg",1253,836,false]},"author_info":{"display_name":"","author_link":"https:\/\/vanillanews.com\/index.php\/author\/"},"category_info":"JUST IN<\/a>","tag_info":"JUST IN","comment_count":"0","_links":{"self":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/posts\/73342"}],"collection":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/comments?post=73342"}],"version-history":[{"count":0,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/posts\/73342\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/media\/73343"}],"wp:attachment":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/media?parent=73342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/categories?post=73342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/tags?post=73342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}